{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:25Z","timestamp":1784139265931,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"am","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.euf.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T04:57:46Z","timestamp":1543553866000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Update on Strategies to Reduce Infectious Complications After Prostate Biopsy"],"prefix":"10.1016","volume":"5","author":[{"given":"Adrian","family":"Pilatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Veeratterapillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6886-0750","authenticated-orcid":false,"given":"Bela","family":"K\u00f6ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-3526","authenticated-orcid":false,"given":"Tommaso","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0021-0302","authenticated-orcid":false,"given":"Riccardo","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Bonkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-8558","authenticated-orcid":false,"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2018.11.009_bib0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0010","unstructured":"UK Department of Health, National schedule of reference costs: the main schedule. https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2014-to-2015."},{"key":"10.1016\/j.euf.2018.11.009_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011. A prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)38663-9","article-title":"Ultrasound guided transrectal core biopsies of the palpably abnormal prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2018.11.009_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2014.12.005","article-title":"Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations","volume":"68","author":"Pilatz","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.02.001","article-title":"Antibiotics may not decrease prostate-specific antigen levels or prevent unnecessary prostate biopsy in patients with moderately increased prostate-specific antigen levels: a meta-analysis","volume":"33","author":"Yang","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2018.11.009_bib0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)56477-0","article-title":"A double-blind study of trimethoprim-sulfamethoxazole prophylaxis in patients having transrectal needle biopsy of the prostate","volume":"122","author":"Ruebush","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006576.pub2","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","author":"Zani","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2018.11.009_bib0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/sur.2015.040","article-title":"Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials","volume":"16","author":"Yang","year":"2015","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.euf.2018.11.009_bib0060","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11255-016-1299-7","article-title":"The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis","volume":"48","author":"Yang","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2018.11.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4635386","article-title":"Addition of ceftriaxone and amikacin to a ciprofloxacin plus metronidazole regimen for preventing infectious complications of transrectal ultrasound-guided prostate biopsy: a randomized controlled trial","volume":"2017","author":"Izadpanahi","year":"2017","journal-title":"Adv Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.aju.2016.05.003","article-title":"Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a prospective randomised study","volume":"14","author":"Fahmy","year":"2016","journal-title":"Arab J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.acuro.2014.01.002","article-title":"Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin","volume":"38","author":"Lista","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2018.11.009_bib0080","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.5489\/cuaj.3068","article-title":"The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: a prospective, randomized, and controlled clinical study","volume":"9","author":"Sen","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2018.11.009_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","article-title":"Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis","volume":"21","author":"Noreikaite","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2018.11.009_bib0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00345-018-2217-7","article-title":"The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis","volume":"36","author":"Scott","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s00345-018-2319-2","article-title":"Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial","author":"Elshal","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.prnil.2016.06.001","article-title":"Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: a prospective randomized study","volume":"4","author":"Fahmy","year":"2016","journal-title":"Prostate Int"},{"key":"10.1016\/j.euf.2018.11.009_bib0105","first-page":"852","article-title":"Prevalence of antibiotic resistance in fecal flora before transrectal ultrasound-guided prostate biopsy and the clinical impact of targeted antibiotic prophylaxis","volume":"70","author":"Ozgur","year":"2017","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-4295(81)90425-8","article-title":"Bacteremia and bacteriuria after transrectal prostatic biopsy","volume":"18","author":"Brown","year":"1981","journal-title":"Urology"},{"key":"10.1016\/j.euf.2018.11.009_bib0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ju.0000099824.73886.f3","article-title":"The incidence of prostate cancer in men with prostate specific antigen greater than 4.0ng\/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy","volume":"171","author":"Emiliozzi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.juro.2012.12.109","article-title":"Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial","volume":"190","author":"Irani","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2004.04928.x","article-title":"Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity","volume":"94","author":"Mariappan","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2018.11.009_bib0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-5347(05)67996-7","article-title":"Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores","volume":"163","author":"Naughton","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2003.12.007","article-title":"Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region?","volume":"45","author":"Paul","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0140","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.juro.2011.02.010","article-title":"Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy","volume":"185","author":"Rodr\u00edguez-Covarrubias","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.pcan.4500713","article-title":"A prospective randomized comparison of extensive prostate biopsy to standard biopsy with assessment of diagnostic yield, biopsy pain and morbidity","volume":"7","author":"Sur","year":"2004","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2018.11.009_bib0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000481830","article-title":"The efficiency and safety of intrarectal topical anesthesia for transrectal ultrasound-guided prostate biopsy: a systematic review and meta-analysis","volume":"99","author":"Yang","year":"2017","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2018.11.009_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4111\/kju.2009.50.2.119","article-title":"The comparison between transperineal and transrectal ultrasound-guided prostate needle biopsy","volume":"50","author":"Chae","year":"2009","journal-title":"Korean J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2007.09.029","article-title":"Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy","volume":"71","author":"Hara","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.euf.2018.11.009_bib0165","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.pcan.4500985","article-title":"A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy","volume":"11","author":"Takenaka","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2018.11.009_bib0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/aja.2011.130","article-title":"The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis","volume":"14","author":"Shen","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.euf.2018.11.009_bib0175","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.euf.2018.11.009_bib0180","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.juro.2012.09.121","article-title":"A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy","volume":"189","author":"Abughosh","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5812\/iranjradiol.7561","article-title":"Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial","volume":"9","author":"Ghafoori","year":"2012","journal-title":"Iran J Radiol"},{"key":"10.1016\/j.euf.2018.11.009_bib0190","first-page":"1621","article-title":"Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial","volume":"92","author":"Kanjanawongdeengam","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.euf.2018.11.009_bib0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-5347(17)53730-1","article-title":"Urinary tract infection after transrectal needle biopsy of the prostate","volume":"127","author":"Sharpe","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02550403","article-title":"Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate","volume":"22","author":"Melekos","year":"1990","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euf.2018.11.009_bib0205","first-page":"609","article-title":"Impact of insertion timing of iodophor cotton ball on the control of infection complications after transrectal ultrasound guided prostate biopsy","volume":"94","author":"Yu","year":"2014","journal-title":"Natl Med J China"},{"key":"10.1016\/j.euf.2018.11.009_bib0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-5347(05)67453-8","article-title":"Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy","volume":"164","author":"Lindert","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0215","first-page":"261","article-title":"The efficiency of prophylactic antibiotic treatment in patients without risk factor who underwent transrectal","volume":"32","author":"Tekdogan","year":"2006","journal-title":"Turk Urol Dergisi"},{"key":"10.1016\/j.euf.2018.11.009_bib0220","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00345-018-2221-y","article-title":"Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial","volume":"36","author":"Salomon","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0225","first-page":"S306","article-title":"Prospective randomized controlled study to assess the effect of perineal region cleansing with povidone iodine before transrectal needle biopsy of the prostate on infectious complications","volume":"84","author":"Taher","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.euf.2018.11.009_bib0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S1677-55382011000100010","article-title":"Reducing infectious complications after transrectal prostate needle biopsy using a disposable needle guide: is it possible?","volume":"37","author":"Gurbuz","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euf.2018.11.009_bib0235","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.urology.2007.11.160","article-title":"Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy?","volume":"71","author":"Tuncel","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.euf.2018.11.009_bib0240","first-page":"119","article-title":"Comparison of patient comfort and complications of transrectal ultrasonography guided prostate biopsies using 16 and 18 Gauge needles","volume":"31","author":"Tas","year":"2005","journal-title":"T\u00fcrk \u00dcrol Dern"},{"key":"10.1016\/j.euf.2018.11.009_bib0245","article-title":"Complications and prostate cancer diagnosis rate of TRUS prostate biopsies using 16 and 18G needles by Clavien scoring","volume":"0","author":"Ozcan","year":"2017","journal-title":"Urologia"},{"key":"10.1016\/j.euf.2018.11.009_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000314340","article-title":"Does washing the biopsy needle with povidone-iodine have an effect on infection rates after transrectal prostate needle biopsy?","volume":"85","author":"Koc","year":"2010","journal-title":"Urol Int"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456918303651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456918303651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:48:22Z","timestamp":1762498102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456918303651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2405456918303651"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2018.11.009","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Strategies to Reduce Infectious Complications After Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}